News – Stanley Capital

Stanley Capital Partners announces realisation of Irish speciality pharma firm Noden Pharma for 6.7x return / 151% IRR

Stanley Capital Partners invests in French pharmaceutical group Laboratoire XO

Stanley Capital Summer 2022 Newsletter

Stanley Capital Spring 2022 Newsletter

Stanley Capital-backed portfolio company DSS acquires My Meds and Me

Applied Artificial Intelligence Corporation and Stanley Capital Announce Partnership to Bring Artificial Intelligence to Private Equity Investments

Stanley Capital Partners acquires Drug Safety Solutions from Astorg and Nordic Capital-backed Clario

Grafine Partners and Stanley Capital Form Strategic Partnership to Invest in Growing Sustainable Businesses

Healthcare AI Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering

PDL BioPharma closes sale of Noden business to Stanley Capital

Stanley Capital Acquires Noden Pharma DAC

Wilkie Press Release

Noden Pharma DAC acquired by Stanley Capital

PDL Biopharma Inc (PDLI) Q2 2020 Earnings Call Transcript

PDL Biopharma Q2 annoucement

Noden Pharma the right medicine in $48.25m deal

PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital

Stanley Capital buys Irish pharma company with a view to consolidate the market

Private Equity News